A detailed history of Teacher Retirement System Of Texas transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Teacher Retirement System Of Texas holds 82,730 shares of VRTX stock, worth $33.8 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
82,730
Previous 73,347 12.79%
Holding current value
$33.8 Million
Previous $34.4 Million 11.92%
% of portfolio
0.19%
Previous 0.2%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$460.0 - $505.78 $4.32 Million - $4.75 Million
9,383 Added 12.79%
82,730 $38.5 Million
Q2 2024

Aug 09, 2024

BUY
$392.81 - $485.53 $563,289 - $696,250
1,434 Added 1.99%
73,347 $34.4 Million
Q1 2024

May 06, 2024

BUY
$407.69 - $446.08 $4.72 Million - $5.16 Million
11,570 Added 19.17%
71,913 $30.1 Million
Q4 2023

Feb 07, 2024

SELL
$343.0 - $410.68 $2.69 Million - $3.21 Million
-7,828 Reduced 11.48%
60,343 $24.6 Million
Q3 2023

Oct 31, 2023

BUY
$338.18 - $362.46 $374,027 - $400,880
1,106 Added 1.65%
68,171 $23.7 Million
Q2 2023

Jul 19, 2023

SELL
$314.42 - $351.91 $6.33 Million - $7.09 Million
-20,138 Reduced 23.09%
67,065 $23.6 Million
Q1 2023

May 12, 2023

SELL
$283.23 - $323.1 $15.3 Million - $17.4 Million
-53,927 Reduced 38.21%
87,203 $27.5 Million
Q4 2022

Feb 10, 2023

SELL
$285.76 - $321.48 $1.42 Million - $1.6 Million
-4,984 Reduced 3.41%
141,130 $40.8 Million
Q3 2022

Nov 03, 2022

BUY
$273.83 - $305.53 $1.61 Million - $1.79 Million
5,874 Added 4.19%
146,114 $42.3 Million
Q2 2022

Aug 09, 2022

SELL
$234.96 - $292.55 $5.24 Million - $6.53 Million
-22,306 Reduced 13.72%
140,240 $39.5 Million
Q1 2022

May 09, 2022

BUY
$221.42 - $260.97 $11 Million - $13 Million
49,786 Added 44.15%
162,546 $42.4 Million
Q4 2021

Feb 10, 2022

SELL
$177.01 - $223.45 $2.92 Million - $3.68 Million
-16,482 Reduced 12.75%
112,760 $24.8 Million
Q3 2021

Nov 09, 2021

SELL
$181.39 - $202.99 $11.5 Million - $12.8 Million
-63,131 Reduced 32.82%
129,242 $23.4 Million
Q2 2021

Aug 05, 2021

BUY
$187.49 - $221.1 $3.15 Million - $3.71 Million
16,775 Added 9.55%
192,373 $38.8 Million
Q1 2021

May 11, 2021

SELL
$207.02 - $241.31 $16.8 Million - $19.6 Million
-81,250 Reduced 31.63%
175,598 $37.7 Million
Q4 2020

Feb 11, 2021

BUY
$207.01 - $276.09 $11.6 Million - $15.4 Million
55,920 Added 27.83%
256,848 $60.7 Million
Q3 2020

Nov 02, 2020

BUY
$255.65 - $303.1 $13.9 Million - $16.4 Million
54,200 Added 36.94%
200,928 $54.7 Million
Q2 2020

Aug 11, 2020

BUY
$225.48 - $295.8 $12.9 Million - $16.9 Million
57,160 Added 63.82%
146,728 $42.6 Million
Q1 2020

May 05, 2020

BUY
$199.77 - $247.81 $7.63 Million - $9.46 Million
38,184 Added 74.31%
89,568 $21.3 Million
Q4 2019

Feb 06, 2020

BUY
$166.71 - $223.91 $4.33 Million - $5.82 Million
25,977 Added 102.24%
51,384 $11.3 Million
Q3 2019

Oct 28, 2019

SELL
$166.23 - $187.09 $945,516 - $1.06 Million
-5,688 Reduced 18.29%
25,407 $4.3 Million
Q2 2019

Aug 05, 2019

BUY
$164.61 - $190.37 $5.12 Million - $5.92 Million
31,095 New
31,095 $5.7 Million
Q1 2019

May 06, 2019

SELL
$163.73 - $194.7 $572,236 - $680,476
-3,495 Closed
0 $0
Q4 2018

Mar 04, 2019

SELL
$151.91 - $192.21 $4.03 Million - $5.1 Million
-26,518 Reduced 88.36%
3,495 $579,000
Q3 2018

Nov 09, 2018

SELL
$167.73 - $192.74 $3.6 Million - $4.14 Million
-21,492 Reduced 41.73%
30,013 $5.79 Million
Q2 2018

Aug 06, 2018

SELL
$145.72 - $169.96 $649,911 - $758,021
-4,460 Reduced 7.97%
51,505 $8.75 Million
Q1 2018

May 08, 2018

SELL
$151.6 - $177.13 $6.54 Million - $7.64 Million
-43,156 Reduced 43.54%
55,965 $9.12 Million
Q4 2017

Feb 06, 2018

BUY
$137.28 - $155.55 $13.1 Million - $14.9 Million
95,730 Added 2823.06%
99,121 $14.9 Million
Q3 2017

Nov 06, 2017

BUY
$148.13 - $162.24 $502,308 - $550,155
3,391
3,391 $516,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.